Company Kancera AB (publ) Nasdaq Stockholm
Equities
SE0015658570
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Selin
CEO | Chief Executive Officer | - | 01/22/01 |
Director of Finance/CFO | 75 | - | |
Johan Schultz
CTO | Chief Tech/Sci/R&D Officer | - | 01/13/01 |
Martin Norin
COO | Chief Operating Officer | 65 | 01/10/01 |
Thomas Olin
CTO | Chief Tech/Sci/R&D Officer | 66 | 05/10/05 |
Markus Jerling
CTO | Chief Tech/Sci/R&D Officer | 72 | 01/23/01 |
Niclas Brynne
PRN | Corporate Officer/Principal | 63 | 01/16/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 05/10/05 | |
Director/Board Member | 66 | 01/16/01 | |
Håkan Mellstedt
FOU | Founder | 82 | 28/10/28 |
Thomas Olin
CTO | Chief Tech/Sci/R&D Officer | 66 | 05/10/05 |
Director/Board Member | 72 | 28/12/28 | |
Director/Board Member | 58 | 30/18/30 | |
Petter Brodin
BRD | Director/Board Member | - | 26/21/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 121,186,228 | 55,214,243 ( 45.56 %) | 0 | 45.56 % |
Company contact information
Kancera AB
Karolinska Institutet Science Park Nanna Svartz Väg 4
171 65, Solna
+46 8 50 12 60 80
http://www.kancera.comSector
1st Jan change | Capi. | |
---|---|---|
+15.82% | 121B | |
+20.35% | 113B | |
+17.47% | 26.02B | |
-25.31% | 19.39B | |
-19.51% | 15.91B | |
-19.67% | 15.09B | |
-46.87% | 15.06B | |
+62.55% | 14.93B | |
+6.34% | 13.85B |